This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Zhejiang Hisun Pharmaceutical Co., Ltd.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: The Innovations of Minghuang Hong
Introduction
Minghuang Hong is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of ginsenoside compounds. With a total of 2 patents, his work has garnered attention in the scientific community.
Latest Patents
Minghuang Hong's latest patents include innovative methods for preparing ginsenoside C-K polymorphic compounds. The first patent provides several types of ginsenoside polymorphic substances, including new crystal forms A, B, C, E, F, I, K, L, M, N, and O. The second patent focuses on two specific crystal forms of ginsenoside C-K, namely crystal form D and crystal form H, along with the methods for preparing these forms.
Career Highlights
Minghuang Hong is currently associated with Zhejiang Hisun Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in enhancing the understanding and application of ginsenoside compounds in the pharmaceutical industry.
Collaborations
Minghuang has collaborated with esteemed colleagues such as Guobin Ren and Changliang Dai, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Minghuang Hong's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator in the industry. His work on ginsenoside compounds is paving the way for future advancements in this area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile